FLECTOR Drug Patent Profile
✉ Email this page to a colleague
When do Flector patents expire, and what generic alternatives are available?
Flector is a drug marketed by Ibsa and is included in one NDA.
The generic ingredient in FLECTOR is diclofenac epolamine. There are forty-seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the diclofenac epolamine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FLECTOR?
- What are the global sales for FLECTOR?
- What is Average Wholesale Price for FLECTOR?
Summary for FLECTOR
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 25 |
Clinical Trials: | 5 |
Patent Applications: | 103 |
Drug Prices: | Drug price information for FLECTOR |
What excipients (inactive ingredients) are in FLECTOR? | FLECTOR excipients list |
DailyMed Link: | FLECTOR at DailyMed |
Recent Clinical Trials for FLECTOR
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Fidia Farmaceutici s.p.a. | Phase 3 |
Fidia Farmaceutici s.p.a. | Phase 1 |
Actavis Inc. | Phase 3 |
Pharmacology for FLECTOR
Drug Class | Nonsteroidal Anti-inflammatory Drug |
Mechanism of Action | Cyclooxygenase Inhibitors |
Physiological Effect | Decreased Prostaglandin Production |
Paragraph IV (Patent) Challenges for FLECTOR
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
FLECTOR | Topical Patch | diclofenac epolamine | 1.3% | 021234 | 1 | 2015-06-26 |
US Patents and Regulatory Information for FLECTOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for FLECTOR
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Ibsa | FLECTOR | diclofenac epolamine | SYSTEM;TOPICAL | 021234-001 | Jan 31, 2007 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for FLECTOR
See the table below for patents covering FLECTOR around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Greece | 3002386 | ⤷ Sign Up | |
European Patent Office | 0621263 | Préparation pour sparadrap analgésique et anti-inflammatoire externe (External anti-inflammatory and analgesic plaster preparation) | ⤷ Sign Up |
South Korea | 960003327 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |